Dupont Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,778
Closed -$77.2K 1022
2022
Q4
$77.2K Sell
27,778
-2,977
-10% -$8.9K ﹤0.01% 1000
2022
Q3
$88K Sell
30,755
-12,046
-28% -$42.8K 0.01% 1082
2022
Q2
$149K Hold
42,801
0.01% 1065
2022
Q1
$202K Sell
42,801
-3,786
-8% -$18.5K 0.01% 1048
2021
Q4
$281K Buy
+46,587
New +$324K 0.01% 998
2021
Q3
Sell
-30,061
Closed -$376K 1778
2021
Q2
$376K Buy
+30,061
New +$326K 0.01% 1118
2018
Q4
Sell
-92,307
Closed -$570K 1196
2018
Q3
$570K Hold
92,307
0.01% 693
2018
Q2
$590K Hold
92,307
0.01% 674
2018
Q1
$643K Hold
92,307
0.02% 613
2017
Q4
$1.16M Hold
92,307
0.03% 489
2017
Q3
$1.1M Sell
92,307
-42,689
-32% -$633K 0.02% 499
2017
Q2
$2.02M Sell
134,996
-8,300
-6% -$111K 0.05% 357
2017
Q1
$1.37M Sell
143,296
-75,416
-34% -$637K 0.03% 445
2016
Q4
$1.94M Hold
218,712
0.04% 336
2016
Q3
$1.88M Hold
218,712
0.04% 316
2016
Q2
$1.75M Buy
218,712
+32,809
+18% +$255K 0.04% 323
2016
Q1
$1.63M Buy
185,903
+85,338
+85% +$709K 0.04% 359
2015
Q4
$942K Buy
100,565
+45,713
+83% +$396K 0.02% 481
2015
Q3
$529K Buy
+54,852
New +$579K 0.01% 530

Other funds holding MDXG

Dupont Capital Management's MDXG Position: Q1 2023 in Review

Dupont Capital Management sold out of MiMedx Group (MDXG) in Q1 2023, closing a stake of 27,778 shares — an estimated $77.2K sold.

Dupont Capital Management first reported a position in MDXG in Q3 2015 and held it in 19 quarters. The position peaked at $2.02M in Q2 2017. 163 funds tracked by Wall St. Rank hold MDXG as of Q1 2023.

  • Dupont Capital Management reported no remaining MiMedx Group position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 27,778 MiMedx Group shares in Q1 2023, an estimated $77.2K.
  • Dupont Capital Management first reported a position in MiMedx Group in Q3 2015 and held it in 19 quarters.
  • Dupont Capital Management's MiMedx Group position peaked at $2.02M in Q2 2017.
  • 163 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.